ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma

ClinicalTrials.gov ID: NCT01041638

Public ClinicalTrials.gov record NCT01041638. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 2:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Comprehensive Safety Trial of Chimeric Antibody 14.18 (Ch14.18) With GM-CSF, IL-2 and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy

Study identification

NCT ID
NCT01041638
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
105 participants

Conditions and interventions

Interventions

  • Aldesleukin Biological
  • Diagnostic Laboratory Biomarker Analysis Other
  • Dinutuximab Biological
  • Isotretinoin Drug
  • Sargramostim Biological

Biological · Other · Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2009
Primary completion
Dec 30, 2013
Completion
Jun 29, 2021
Last update posted
Aug 16, 2021

2009 – 2021

United States locations

U.S. sites
32
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Loma Linda University Medical Center Loma Linda California 92354
Children's Hospital Los Angeles Los Angeles California 90027
Children's Hospital of Orange County Orange California 92868
Lucile Packard Children's Hospital Stanford University Palo Alto California 94304
Rady Children's Hospital - San Diego San Diego California 92123
UCSF Medical Center-Mount Zion San Francisco California 94115
UCSF Medical Center-Parnassus San Francisco California 94143
Children's Hospital Colorado Aurora Colorado 80045
Children's Healthcare of Atlanta - Egleston Atlanta Georgia 30322
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202
Riley Hospital for Children Indianapolis Indiana 46202
Children's Hospital New Orleans New Orleans Louisiana 70118
Dana-Farber Cancer Institute Boston Massachusetts 02215
C S Mott Children's Hospital Ann Arbor Michigan 48109
Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis Minnesota 55404
University of Minnesota/Masonic Cancer Center Minneapolis Minnesota 55455
Children's Mercy Hospitals and Clinics Kansas City Missouri 64108
Washington University School of Medicine St Louis Missouri 63110
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032
New York Medical College Valhalla New York 10595
Duke University Medical Center Durham North Carolina 27710
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Saint Jude Children's Research Hospital Memphis Tennessee 38105
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390
Cook Children's Medical Center Fort Worth Texas 76104
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston Texas 77030
Seattle Children's Hospital Seattle Washington 98105
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01041638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 16, 2021 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01041638 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →